COVID-19 stokes inflammasomes

The poor success rate of treating patients with aggressive sepsis in SARS-CoV-2 infections has highlighted again the challenges of managing systemic inflammatory conditions. In this issue of JEM, Rodrigues et al. (https://doi.org/10.1084/jem.20201707) discuss the role of inflammasome activation in C...

Descripción completa

Detalles Bibliográficos
Autor principal: Bryant, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Insights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731946/
https://www.ncbi.nlm.nih.gov/pubmed/33289787
http://dx.doi.org/10.1084/jem.20202413
_version_ 1783621997578682368
author Bryant, Clare
author_facet Bryant, Clare
author_sort Bryant, Clare
collection PubMed
description The poor success rate of treating patients with aggressive sepsis in SARS-CoV-2 infections has highlighted again the challenges of managing systemic inflammatory conditions. In this issue of JEM, Rodrigues et al. (https://doi.org/10.1084/jem.20201707) discuss the role of inflammasome activation in COVID-19 disease severity, opening new possibilities for therapeutic management of sepsis syndromes.
format Online
Article
Text
id pubmed-7731946
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-77319462020-12-15 COVID-19 stokes inflammasomes Bryant, Clare J Exp Med Insights The poor success rate of treating patients with aggressive sepsis in SARS-CoV-2 infections has highlighted again the challenges of managing systemic inflammatory conditions. In this issue of JEM, Rodrigues et al. (https://doi.org/10.1084/jem.20201707) discuss the role of inflammasome activation in COVID-19 disease severity, opening new possibilities for therapeutic management of sepsis syndromes. Rockefeller University Press 2020-12-08 /pmc/articles/PMC7731946/ /pubmed/33289787 http://dx.doi.org/10.1084/jem.20202413 Text en © 2020 Bryant http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Insights
Bryant, Clare
COVID-19 stokes inflammasomes
title COVID-19 stokes inflammasomes
title_full COVID-19 stokes inflammasomes
title_fullStr COVID-19 stokes inflammasomes
title_full_unstemmed COVID-19 stokes inflammasomes
title_short COVID-19 stokes inflammasomes
title_sort covid-19 stokes inflammasomes
topic Insights
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731946/
https://www.ncbi.nlm.nih.gov/pubmed/33289787
http://dx.doi.org/10.1084/jem.20202413
work_keys_str_mv AT bryantclare covid19stokesinflammasomes

Ejemplares similares